関連する実験動画

Updated: Feb 18, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

転移性新生児低血糖症と発達中の脳:関連性,メカニズム,臨床的影響

Maria F Martinez-Alcala¹, Blanca V Velez-Rangel^2,3, Cristian F Lozano-Vazquez²

¹Faculty of Medicine, Anahuac University - Mexico Norte, Huixquilucan, Mexico.

Journal of neonatal-perinatal medicine

|February 17, 2026

まとめ

転移性新生児低血糖症 (TNH) は,乳児の神経発達,特に執行機能に影響を与える可能性があります. 常に有害ではないが,高リスクの乳児におけるTNHは,潜在的な長期的な効果のために注意深くモニタリングと管理を保証する.

科学分野:

新生児医学新生児医学
神経科学は神経科学である.
発達小児科発達小児科

背景:

転移性新生児低血糖症 (TNH) は歴史的に良性と考えられてきました.
TNHは,新生児の低血糖値 (典型的には<47 mg/dL) を含む.
新興の証拠は,特定のTNHパターンを,後の神経発達の問題と関連付けています.

研究の目的:

長期的な脳発達に対するTNHの影響に関する証拠をレビューする.
ドメイン特有の神経発達の結果に焦点を当てます.
臨床的,疫学的,および機械学的データを合成する.

主な方法:

ヒトの研究の構造化されたナラティブレビュー.
TNH,継続的なグルコースモニタリング,および神経発達のアウトカムを含む.
統合された人口ベースのコホート,臨床研究,および体系的なレビュー.

主要な成果:

TNHは選択的な神経発達の違い (執行機能,視覚運動能力,識字能力) と関連しています.
グローバル・コグニティブ・スコアは,しばしば保存され続けます.
特に高リスクの乳児において,再発/長期にわたるTNHは,後の困難とより密接に関連しています.

結論:

TNHは,特定の幼児サブグループにおける神経発達の脆弱性の増加を意味します.
均一に無害でもなければ,必然的に有害でもない.
リスクの高い新生児の早期発見,情報に基づいた治療,長期のフォローアップが必要です.

キーワード:

遺伝的脆弱性遺伝的脆弱性遺伝的脆弱性グルコースグルコースグルコースメタボリック・ヘルスメタボリック・ヘルス神経発達状態である.ニューロンの多様性産前期生児についてです.新生児における一時的な低血糖症

さらに関連する動画

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats

Published on: April 21, 2017

関連する概念動画

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...